Brain tumor patients get virus injections in new hope trial
NCT ID NCT07145047
First seen Jan 11, 2026 · Last updated Apr 26, 2026 · Updated 17 times
Summary
This study tests a virus that targets cancer cells in people with recurrent glioblastoma, a severe brain cancer that has come back after standard treatments. About 20 participants will receive up to 6 injections of the virus directly into the tumor over several weeks. The main goals are to see if the treatment is safe and if it can shrink or control the tumor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mianyang Central Hospital
RECRUITINGMianyang, Sichuan, 621000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.